Evaluating insomnia in patients with metastatic lung cancer
Insomnia in Patients With Metastatic Non Small Cell Lung Cancer
Mayo Clinic · NCT06472804
This study looks at how common sleep problems are in people with advanced lung cancer to better understand their struggles with insomnia.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic (other) |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT06472804 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence of insomnia among patients diagnosed with metastatic non-small cell lung cancer. Participants will undergo a review of their medical charts and complete a questionnaire to provide insights into their sleep difficulties. The study focuses on patients receiving various lines of treatment or maintenance therapy, allowing for a comprehensive understanding of insomnia in this population.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old diagnosed with metastatic non-small cell lung cancer who are undergoing treatment.
Not a fit: Patients with advanced terminal cancer, severe psychiatric disorders, or other specific sleep disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for insomnia in patients with metastatic lung cancer, enhancing their overall quality of life.
How similar studies have performed: While this study focuses on a specific population, similar observational studies have successfully identified sleep issues in cancer patients, suggesting potential for meaningful insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have a diagnosis of metastatic non small cell lung cancer * Undergoing 1st, 2nd or 3rd line of treatment or are in maintenance therapy * Older than 18 years old at the time of diagnosis Exclusion Criteria: * Subjects will be excluded if they are considered to have advanced terminal cancer, severe depression or other psychiatric disorder or a sleep disorder other than insomnia (sleep apnea, restless leg syndrome, sleep related disorder of breathing), regular use of psychotropic medication other than hypnotics (eg antidepressants) per chart review
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (RECRUITING)
Study contacts
- Principal investigator: Konstantinos Leventakos, M.D., Ph.D. — Mayo Clinic in Rochester
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8